Aria Vaishnavi

2.2k total citations · 2 hit papers
9 papers, 974 citations indexed

About

Aria Vaishnavi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Aria Vaishnavi has authored 9 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Aria Vaishnavi's work include Lung Cancer Treatments and Mutations (6 papers), Cancer therapeutics and mechanisms (3 papers) and HER2/EGFR in Cancer Research (2 papers). Aria Vaishnavi is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer therapeutics and mechanisms (3 papers) and HER2/EGFR in Cancer Research (2 papers). Aria Vaishnavi collaborates with scholars based in United States, Netherlands and France. Aria Vaishnavi's co-authors include Robert C. Doebele, Anh‐Tuan Le, Marileila Varella‐Garcia, Anh T. Le, Dara L. Aisner, Stephen B. Keysar, Antonio Jimeno, Jennifer A. Low, Lara E. Davis and Deborah Morosini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Aria Vaishnavi

9 papers receiving 965 citations

Hit Papers

TRKing Down an Old Oncogene in a New Era of Targeted Therapy 2014 2026 2018 2022 2014 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TRKing Down an Old Oncogene in a New Era of Targeted Therapy
    2014 464 citations Aria Vaishnavi, Anh‐Tuan Le et al. Cancer Discovery profile →
  2. An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
    2015 302 citations Robert C. Doebele, Lara E. Davis et al. Cancer Discovery profile →

Peers

Aria Vaishnavi
Tatsushi Kodama Japan
Johannes M. Heuckmann Germany
Fabian Mairinger Germany
Mary Ann Melnick United States
Gaëlle Klingelschmitt Switzerland
Marie‐Paule Sablin France
Pamela Drullinsky United States
Graham H.P. Richmond United Kingdom
Elena Geuna Italy
Hayriye V. Erkizan United States
Tatsushi Kodama Japan
Aria Vaishnavi
Citations per year, relative to Aria Vaishnavi Aria Vaishnavi (= 1×) peers Tatsushi Kodama

Countries citing papers authored by Aria Vaishnavi

Since Specialization
Citations

This map shows the geographic impact of Aria Vaishnavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aria Vaishnavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aria Vaishnavi more than expected).

Fields of papers citing papers by Aria Vaishnavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aria Vaishnavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aria Vaishnavi. The network helps show where Aria Vaishnavi may publish in the future.

Co-authorship network of co-authors of Aria Vaishnavi

This figure shows the co-authorship network connecting the top 25 collaborators of Aria Vaishnavi. A scholar is included among the top collaborators of Aria Vaishnavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aria Vaishnavi. Aria Vaishnavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Planchard, David, Rachel E. Sanborn, Marcelo V. Negrão, Aria Vaishnavi, & Egbert F. Smit. (2024). BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape. npj Precision Oncology. 8(1). 90–90. 12 indexed citations
2.
Vaishnavi, Aria, Conan G. Kinsey, & Martin McMahon. (2023). Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse. Cold Spring Harbor Perspectives in Medicine. 14(1). a041385–a041385. 3 indexed citations
3.
Vaishnavi, Aria, Conan G. Kinsey, Amanda Truong, et al.. (2020). Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer. Cell Reports. 32(5). 107994–107994. 17 indexed citations
4.
Le, Anh T., Adriana Estrada‐Bernal, Laura Schubert, et al.. (2018). Abstract A29: The CUTO panel of patient-derived NSCLC cell lines reveals unique molecular characteristics and responses to targeted therapies. Clinical Cancer Research. 24(17_Supplement). A29–A29. 2 indexed citations
5.
Vaishnavi, Aria, Laura Schubert, Uwe Rix, et al.. (2017). EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases. Cancer Research. 77(13). 3551–3563. 61 indexed citations
6.
Doebele, Robert C., Lara E. Davis, Aria Vaishnavi, et al.. (2015). An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101. Cancer Discovery. 5(10). 1049–1057. 302 indexed citations breakdown →
7.
Vaishnavi, Aria, Anh‐Tuan Le, & Robert C. Doebele. (2014). TRKing Down an Old Oncogene in a New Era of Targeted Therapy. Cancer Discovery. 5(1). 25–34. 464 indexed citations breakdown →
8.
Davies, Kurtis D., David P. Astling, Dara L. Aisner, et al.. (2013). Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer. PLoS ONE. 8(12). e82236–e82236. 104 indexed citations
9.
Doebele, Robert C., Aria Vaishnavi, Marzia Capelletti, et al.. (2013). NTRK1 gene fusions as a novel oncogene target in lung cancer.. Journal of Clinical Oncology. 31(15_suppl). 8023–8023. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsushi Kodama Breakdown of academic impact, for papers by Johannes M. Heuckmann Breakdown of academic impact, for papers by Fabian Mairinger Breakdown of academic impact, for papers by Mary Ann Melnick Breakdown of academic impact, for papers by Gaëlle Klingelschmitt Breakdown of academic impact, for papers by Marie‐Paule Sablin Breakdown of academic impact, for papers by Pamela Drullinsky Breakdown of academic impact, for papers by Graham H.P. Richmond Breakdown of academic impact, for papers by Elena Geuna Breakdown of academic impact, for papers by Hayriye V. Erkizan
Rankless by CCL
2026